These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
474 related articles for article (PubMed ID: 23348977)
1. Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial. Horeweg N; van der Aalst CM; Thunnissen E; Nackaerts K; Weenink C; Groen HJ; Lammers JW; Aerts JG; Scholten ET; van Rosmalen J; Mali W; Oudkerk M; de Koning HJ Am J Respir Crit Care Med; 2013 Apr; 187(8):848-54. PubMed ID: 23348977 [TBL] [Abstract][Full Text] [Related]
2. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers. Horeweg N; Scholten ET; de Jong PA; van der Aalst CM; Weenink C; Lammers JW; Nackaerts K; Vliegenthart R; ten Haaf K; Yousaf-Khan UA; Heuvelmans MA; Thunnissen E; Oudkerk M; Mali W; de Koning HJ Lancet Oncol; 2014 Nov; 15(12):1342-50. PubMed ID: 25282284 [TBL] [Abstract][Full Text] [Related]
3. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial. Walter JE; Heuvelmans MA; de Jong PA; Vliegenthart R; van Ooijen PMA; Peters RB; Ten Haaf K; Yousaf-Khan U; van der Aalst CM; de Bock GH; Mali W; Groen HJM; de Koning HJ; Oudkerk M Lancet Oncol; 2016 Jul; 17(7):907-916. PubMed ID: 27283862 [TBL] [Abstract][Full Text] [Related]
4. Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval. Yousaf-Khan U; van der Aalst C; de Jong PA; Heuvelmans M; Scholten E; Lammers JW; van Ooijen P; Nackaerts K; Weenink C; Groen H; Vliegenthart R; Ten Haaf K; Oudkerk M; de Koning H Thorax; 2017 Jan; 72(1):48-56. PubMed ID: 27364640 [TBL] [Abstract][Full Text] [Related]
5. The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer. Field JK; Duffy SW; Baldwin DR; Brain KE; Devaraj A; Eisen T; Green BA; Holemans JA; Kavanagh T; Kerr KM; Ledson M; Lifford KJ; McRonald FE; Nair A; Page RD; Parmar MK; Rintoul RC; Screaton N; Wald NJ; Weller D; Whynes DK; Williamson PR; Yadegarfar G; Hansell DM Health Technol Assess; 2016 May; 20(40):1-146. PubMed ID: 27224642 [TBL] [Abstract][Full Text] [Related]
6. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening. Horeweg N; van Rosmalen J; Heuvelmans MA; van der Aalst CM; Vliegenthart R; Scholten ET; ten Haaf K; Nackaerts K; Lammers JW; Weenink C; Groen HJ; van Ooijen P; de Jong PA; de Bock GH; Mali W; de Koning HJ; Oudkerk M Lancet Oncol; 2014 Nov; 15(12):1332-41. PubMed ID: 25282285 [TBL] [Abstract][Full Text] [Related]
7. Nodule management protocol of the NELSON randomised lung cancer screening trial. Xu DM; Gietema H; de Koning H; Vernhout R; Nackaerts K; Prokop M; Weenink C; Lammers JW; Groen H; Oudkerk M; van Klaveren R Lung Cancer; 2006 Nov; 54(2):177-84. PubMed ID: 16989922 [TBL] [Abstract][Full Text] [Related]
8. Lung cancer screening with low-dose computed tomography: Experiences from a tertiary hospital in Taiwan. Chen CY; Chen CH; Shen TC; Cheng WC; Hsu CN; Liao CH; Chen CY; Hsia TC; Liao WC; Tu CY; Shih CM; Hsu WH J Formos Med Assoc; 2016 Mar; 115(3):163-70. PubMed ID: 26714425 [TBL] [Abstract][Full Text] [Related]
9. Results of the Randomized Danish Lung Cancer Screening Trial with Focus on High-Risk Profiling. Wille MM; Dirksen A; Ashraf H; Saghir Z; Bach KS; Brodersen J; Clementsen PF; Hansen H; Larsen KR; Mortensen J; Rasmussen JF; Seersholm N; Skov BG; Thomsen LH; Tønnesen P; Pedersen JH Am J Respir Crit Care Med; 2016 Mar; 193(5):542-51. PubMed ID: 26485620 [TBL] [Abstract][Full Text] [Related]
10. Different efficacy of CT screening for lung cancer according to histological type: analysis of Japanese-smoker cases detected using a low-dose CT screen. Kondo R; Yoshida K; Kawakami S; Shiina T; Kurai M; Takasuna K; Yamamoto H; Koizumi T; Honda T; Kubo K Lung Cancer; 2011 Dec; 74(3):433-40. PubMed ID: 21663995 [TBL] [Abstract][Full Text] [Related]
11. Screening for Lung Cancer With Low-Dose Computed Tomography: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. Jonas DE; Reuland DS; Reddy SM; Nagle M; Clark SD; Weber RP; Enyioha C; Malo TL; Brenner AT; Armstrong C; Coker-Schwimmer M; Middleton JC; Voisin C; Harris RP JAMA; 2021 Mar; 325(10):971-987. PubMed ID: 33687468 [TBL] [Abstract][Full Text] [Related]
12. Risk stratification based on screening history: the NELSON lung cancer screening study. Yousaf-Khan U; van der Aalst C; de Jong PA; Heuvelmans M; Scholten E; Walter J; Nackaerts K; Groen H; Vliegenthart R; Ten Haaf K; Oudkerk M; de Koning H Thorax; 2017 Sep; 72(9):819-824. PubMed ID: 28360223 [TBL] [Abstract][Full Text] [Related]
13. Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography. Infante M; Cavuto S; Lutman FR; Passera E; Chiarenza M; Chiesa G; Brambilla G; Angeli E; Aranzulla G; Chiti A; Scorsetti M; Navarria P; Cavina R; Ciccarelli M; Roncalli M; Destro A; Bottoni E; Voulaz E; Errico V; Ferraroli G; Finocchiaro G; Toschi L; Santoro A; Alloisio M; Am J Respir Crit Care Med; 2015 May; 191(10):1166-75. PubMed ID: 25760561 [TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness analysis of a lung cancer screening program in the netherlands: a simulation based on NELSON and NLST study outcomes. Ten Berge H; Willems B; Pan X; Dvortsin E; Aerts J; Postma MJ; Prokop M; van den Heuvel MM J Med Econ; 2024; 27(1):1197-1211. PubMed ID: 39291295 [TBL] [Abstract][Full Text] [Related]
15. Computed tomography screening for lung cancer: results of ten years of annual screening and validation of cosmos prediction model. Veronesi G; Maisonneuve P; Rampinelli C; Bertolotti R; Petrella F; Spaggiari L; Bellomi M Lung Cancer; 2013 Dec; 82(3):426-30. PubMed ID: 24099665 [TBL] [Abstract][Full Text] [Related]
16. Volumetric computed tomography screening for lung cancer: three rounds of the NELSON trial. Horeweg N; van der Aalst CM; Vliegenthart R; Zhao Y; Xie X; Scholten ET; Mali W; Thunnissen E; Weenink C; Groen HJ; Lammers JW; Nackaerts K; van Rosmalen J; Oudkerk M; de Koning HJ Eur Respir J; 2013 Dec; 42(6):1659-67. PubMed ID: 23845716 [TBL] [Abstract][Full Text] [Related]
17. Quantification of growth patterns of screen-detected lung cancers: The NELSON study. Heuvelmans MA; Vliegenthart R; de Koning HJ; Groen HJM; van Putten MJAM; Yousaf-Khan U; Weenink C; Nackaerts K; de Jong PA; Oudkerk M Lung Cancer; 2017 Jun; 108():48-54. PubMed ID: 28625647 [TBL] [Abstract][Full Text] [Related]
18. Characteristics of new solid nodules detected in incidence screening rounds of low-dose CT lung cancer screening: the NELSON study. Walter JE; Heuvelmans MA; Bock GH; Yousaf-Khan U; Groen HJM; Aalst CMV; Nackaerts K; Ooijen PMAV; Koning HJ; Vliegenthart R; Oudkerk M Thorax; 2018 Aug; 73(8):741-747. PubMed ID: 29661918 [TBL] [Abstract][Full Text] [Related]
19. Lung cancer screening using low-dose computed tomography in at-risk individuals: the Toronto experience. Menezes RJ; Roberts HC; Paul NS; McGregor M; Chung TB; Patsios D; Weisbrod G; Herman S; Pereira A; McGregor A; Dong Z; Sitartchouk I; Boerner S; Tsao MS; Keshavjee S; Shepherd FA Lung Cancer; 2010 Feb; 67(2):177-83. PubMed ID: 19427055 [TBL] [Abstract][Full Text] [Related]
20. Reply: stage distribution of lung cancers detected by computed tomography screening in the NELSON Trial. Horeweg N; de Koning HJ Am J Respir Crit Care Med; 2013 Oct; 188(8):1035-6. PubMed ID: 24127806 [No Abstract] [Full Text] [Related] [Next] [New Search]